Identification of the Novel Lincosamide Resistance Gene lnu (E) Truncated by ISEnfa5-cfr-IS Enfa5 Insertion in Streptococcus suis: De Novo Synthesis and Confirmation of Functional Activity in Staphylococcus aureus
Author(s) -
Qin Zhao,
Sarah Wendlandt,
Hui Li,
Jun Li,
Congming Wu,
Jianzhong Shen,
Štefan Schwarz,
Yang Wang
Publication year - 2013
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.02007-13
Subject(s) - lincomycin , biology , streptococcus suis , shuttle vector , gene , lincosamides , microbiology and biotechnology , genetics , staphylococcus aureus , bacteria , vector (molecular biology) , antibiotics , recombinant dna , virulence
The novel lincosamide resistance gene lnu(E), truncated by insertion of an ISEnfa5-cfr-ISEnfa5 segment, was identified in Streptococcus suis. The gene lnu(E) encodes a 173-amino-acid protein with ≤69.4% identity to other lincosamide nucleotidyltransferases. The lnu(E) gene and its promoter region were de novo synthesized, and Staphylococcus aureus RN4220 carrying a shuttle vector with the cloned lnu(E) gene showed a 16-fold increase in the lincomycin MIC. Mass spectrometry experiments demonstrated that Lnu(E) catalyzed the nucleotidylation of lincomycin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom